Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Todos Med Ltd. TOMD
(Total Views: 253)
Posted On: 09/14/2022 7:55:25 PM
Post# of 1418
Avatar
Posted By: redspeed
Re: redspeed #1240
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection - September 14, 2022

Mucosal IgA can provide immunity against respiratory viruses.1 Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) boosts mucosal IgA responses,2 and neutralizing IgA, including neutralizing IgA against the B.1.1.529 (omicron) variant of SARS-CoV-2, has been detected after infection with wild-type SARS-CoV-2.3 However, the potential role of mucosal IgA in protection against SARS-CoV-2 infection is still largely unknown.

https://www.nejm.org/doi/full/10.1056/NEJMc2209651


3cl protease cleaves IgA. Cleave means it split or sever the IgA.

Guess what stops the 3cl protease from replication thus cleaving IgA which provides immunity against respiratory viruses?

If you said Tollovid. BINGO!


Gerald Commissiong@G_Commish
"3CLpro cleaves IgA. We have IP on this. One of the reasons Tollovid is a big deal"













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site